Biobank and Precision Medicine
Biobanks that store biological samples, such as blood and tissue, for future research are becoming increasingly important in understanding the genetic and molecular contributions to disease, health outcomes and treatment.
Started by the Palo Alto Medical Foundation Research Institute (PAMFRI), and already gaining support of generous donors throughout our community, we will now expand the charter of our program to link together blood sample data (DNA, RNA, lipids and proteins) and electronic health record data (such as blood pressure and weight) from consenting patients throughout the region, which will enable researchers to better understand how people develop diseases over time.
This Biobank will allow scientists to study diverse populations across more than 100 communities in Northern California, including people from various genetic and cultural backgrounds. Research findings from the Sutter Health Biobank will not only benefit our patients, but patients all over the world leading through the possibility to develop more personalized treatments and improved health care.
Made possible by the Sutter Biobank, the Precision Medicine initiative drives revolutionary changes in individualized treatment and care for patients. Our highly diverse patient base, billion dollar investment in electronic health records, existing research and infrastructure capabilities and a centralized biobank laboratory facility will allow our health system to conduct research faster and at a lower cost. Precision Medicine provides clinicians with tools, knowledge and therapies to select which treatments work best for each patient based on their genetics, environment, preferences and needs.GrayW2@pamf.org or Lauri Medeiros at 650-696-7857 or firstname.lastname@example.org.